Telephone: 0422 835 700
Email: christa@acadd.com.au
ABN 30 501 882 472
NON REGISTERED
PROVIDER
The Australian Counsel on Alcoholism and Drug Dependence
ABN 70657613295
NOT FOR PROFIT
Hello and Welcome
Clinical Trials
First Human
Clinical Trial NR
CLINICAL TRIAL- Safety & Efficacy of Nicotinamide Riboside Supplementation for Improving Physiological Function in Middle-Aged and Older Adults
LISTED COMPLIMENTARY MEDICINES
Complementary medicines (also known as 'traditional' or 'alternative' medicines) include vitamin, mineral, herbal, aromatherapy and homoeopathic products.
4 May 2018
To be a listed medicine on the Australian Register of Therapeutic Goods (ARTG) a product:read on
-
Standards, guidelines & publications (complementary medicines)
Guidance on the regulatory requirements for complementary medicines -
Forms for complementary medicine sponsors
Application forms for sponsors of complementary medicines -
Complementary medicines reforms
Progress of complementary medicine reforms -
Regulatory decisions & notices (complementary medicines)
Information for complementary medicine sponsors, manufacturers and consumers
Complementary medicine regulation basics
NAD Deficiency, Congenital Malformations, and Niacin Supplementation Aug 10th 2017 read on
Niacin, an old supplement with a new twist- read on
Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD+ precursor vitamins in human nutrition. read on
Nicotinamide Improves Aspects of Healthspan, but Not Lifespan, in Mice. read on
Emerging Potential Benefits of Modulating NAD+ Metabolism in Cardiovascular Disease. read on
Nicotinamide riboside, a form of vitamin B3, protects against excitotoxicity-induced axonal degeneration. read on
Nicotinamide Riboside Is a Major NAD+ Precursor Vitamin in Cow Milk.
Nicotinamide riboside, a trace nutrient in foods, is a Vitamin B3 with effects on energy metabolism and neuroprotection read on
Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults
Nicotinamide adenine dinucleotide (NAD+) has emerged as a critical co-substrate for enzymes involved in the beneficial effects of regular calorie restriction on healthspan. As such, the use of NAD+ precursors to augment NAD+ bioavailability has been proposed as a strategy for improving cardiovascular and other physiological functions with aging in humans. Here we provide the evidence in a 2 × 6-week randomized, double-blind, placebo-controlled, crossover clinical trial that chronic supplementation with the NAD+ precursor vitamin, nicotinamide riboside (NR), is well tolerated and effectively stimulates NAD+metabolism in healthy middle-aged and older adults. Our results also provide initial insight into the effects of chronic NR supplementation on physiological function in humans, and suggest that, in particular, future clinical trials should further assess the potential benefits of NR for reducing blood pressure and arterial stiffness in this group.read on
Metabolic Roles of Niacin To fulfill its metabolic roles, niacin is initially incorporated into NAD+, which may be subsequently phosphorylated to form NAD(P)+, allowing enzyme selectivity (1). read on
Clinical Trials and Niacin Pharmacological doses of nicotinic acid (1–3 g/d) reduce serum LDL cholesterol and increase serum HDL cholesterol, suggesting potential clinical benefits for the prevention and treatment of cardiovascular diseases (CVDs) (4). read on
Vascular endothelial function and oxidative stress are related to dietary niacin intake among healthy middle-aged and older adults read on